Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial

• Sin Gon Kim,

  Affiliation Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea

  ⨯
• Doo Man Kim,

  Affiliation Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea

  ⨯
• Jeong-Taek Woo,

  Affiliation Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea

  ⨯
• Hak Chul Jang,

  Affiliation Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

  ⨯
• Choon Hee Chung,

  Affiliation Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Korea

  ⨯
• Kyung Soo Ko,

  Affiliation Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea

  ⨯
• Jeong Hyun Park,

  Affiliation Department of Internal Medicine, Inje University Pusan Paik Hospital, Pusan, Korea

  ⨯
• Yong Soo Park,

  Affiliation Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea

  ⨯
• Sang Jin Kim,

  Affiliation Department of Internal Medicine, Soon Chun Hyang University Cheonan Hospital, Cheonan, Korea

  ⨯
• Dong Seop Choi

  * E-mail: cdongs@kumc.or.kr

  Affiliation Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea

  ⨯